|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
52382157
???header.onlineuser??? :
940
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"vermorken j"???jsp.browse.items-by-author.description???
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
| 國立成功大學 |
2015-12-01 |
Phase 3 trial of pembrolizumab as a first-line treatment in subjects with recurrent/metastatic head and neck squamous cell carcinoma: KEYNOTE-048
|
Yen, C. J.; Klochikhin, A.; Cohen, E.; Vermorken, J.; Harrington, K.; Tahara, M.; Ge, Y.; Geib, J.; Jin, F.; Burtness, B. |
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
|